This compound is primarily utilized in the pharmaceutical industry as a broad-spectrum antibiotic, particularly effective against a wide range of Gram-positive and Gram-negative bacteria. Its mechanism of action involves inhibiting bacterial cell wall synthesis, making it a potent agent in treating severe infections such as pneumonia, sepsis, and urinary tract infections. It is often administered intravenously in hospital settings for patients with serious bacterial infections where oral antibiotics are ineffective. Additionally, its stability against beta-lactamase enzymes enhances its efficacy against resistant bacterial strains. Research continues to explore its potential in combination therapies to combat multidrug-resistant pathogens.